Imagine two pharmaceutical companies that employ the same job categories but different business strategies. One tries to increase its market share through innovation (developing new and better drugs). The other sticks to established products and tries to increase its market share by lowering costs. Why might the two firms wind up with dramatically different pay-for-performance programs? What types of programs might be most and least suitable to each organization?